Effect of pregnancy on the pharmacokinetic interaction between efavirenz and lumefantrine in HIV-malaria co-infection

about

Effect of pregnancy on the pharmacokinetic interaction between efavirenz and lumefantrine in HIV-malaria co-infection

Item

http://www.wikidata.org/entity/Q56346858

description

article

@en

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

ലേഖനം

@ml

name

Effect of pregnancy on the pha ...... ne in HIV-malaria co-infection

@en

Effect of pregnancy on the pha ...... ne in HIV-malaria co-infection

@nl

type

Item

label

Effect of pregnancy on the pha ...... ne in HIV-malaria co-infection

@en

Effect of pregnancy on the pha ...... ne in HIV-malaria co-infection

@nl

prefLabel

Effect of pregnancy on the pha ...... ne in HIV-malaria co-infection

@en

Effect of pregnancy on the pha ...... ne in HIV-malaria co-infection

@nl

P1476

Effect of pregnancy on the pha ...... ne in HIV-malaria co-infection

@en

P2093

Adebanjo Adegbola

http://www.w3.org/2001/XMLSchema#string

Andrew Owen

http://www.w3.org/2001/XMLSchema#string

Julius Soyinka

http://www.w3.org/2001/XMLSchema#string

Marco Siccardi

http://www.w3.org/2001/XMLSchema#string

Oluseye Bolaji

http://www.w3.org/2001/XMLSchema#string

Omotade Ijarotimi

http://www.w3.org/2001/XMLSchema#string

Rana Abutaima

http://www.w3.org/2001/XMLSchema#string

P2860

A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy

Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women

Efavirenz primary and secondary metabolism in vitro and in vivo: identification of novel metabolic pathways and cytochrome P450 2A6 as the principal catalyst of efavirenz 7-hydroxylation

CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance

Use of a physiologically-based pharmacokinetic model to simulate artemether dose adjustment for overcoming the drug-drug interaction with efavirenz.

Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.

Pharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfection.

Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implications

Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum.

The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients.

P31

scholarly article

P356

10.1128/AAC.01252-18

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

Adeniyi Olagunju

P577

2018-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30082286

http://www.w3.org/2001/XMLSchema#string

P921

malaria

pregnancy-associated malaria

P932

6153791

http://www.w3.org/2001/XMLSchema#string